Expertise in
5
conditions

Dr. Russell Devore

Hematology | Oncology
Tennessee Cancer Specialists PLLC
1415 Old Weisgarber Rd Ste 200, 
Knoxville, TN 
Expertise in
5
conditions
Tennessee Cancer Specialists PLLC
1415 Old Weisgarber Rd Ste 200, 
Knoxville, TN 

Overview

Russell Devore is a Hematologist and an Oncologist in Knoxville, Tennessee. Dr. Devore is highly rated in 5 conditions, according to our data. His top areas of expertise are Hypersplenism, Pleuropulmonary Blastoma, Childhood Iron Deficiency Anemia, and Lung Cancer.

His clinical research consists of co-authoring 5 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in KY

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Tennessee Cancer Specialists PLLC
1415 Old Weisgarber Rd Ste 200, Knoxville, TN 37909

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase I, Open-label, Multiple-ascending Dose Trial to Investigate the Safety, Tolerability, PK, Biological and Clinical Activity of MSB0011359C in Subjects With Metastatic or Locally Advanced Solid Tumors and Expansion to Selected Indications
A Phase I, Open-label, Multiple-ascending Dose Trial to Investigate the Safety, Tolerability, PK, Biological and Clinical Activity of MSB0011359C in Subjects With Metastatic or Locally Advanced Solid Tumors and Expansion to Selected Indications
Enrollment Status: Completed
Publish Date: May 03, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Two-part, Open-label, Randomized, Phase 2/3 Study of Dinutuximab and Irinotecan Versus Irinotecan for Second Line Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer
A Two-part, Open-label, Randomized, Phase 2/3 Study of Dinutuximab and Irinotecan Versus Irinotecan for Second Line Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: December 09, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2/Phase 3
An Open-label, Multi-center, Expanded Treatment Protocol (ETP) of Oral LDK378 in Adult Patients With Non-small Cell Lung Cancer (NSCLC) Characterized by ALK Positivity
An Open-label, Multi-center, Expanded Treatment Protocol (ETP) of Oral LDK378 in Adult Patients With Non-small Cell Lung Cancer (NSCLC) Characterized by ALK Positivity
Enrollment Status: No_longer_available
Publish Date: November 03, 2020
Intervention Type: Drug
Phase 1b/2a Safety and Pharmacokinetic Study of G1T28 in Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Etoposide and Carboplatin
Phase 1b/2a Safety and Pharmacokinetic Study of G1T28 in Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Etoposide and Carboplatin
Enrollment Status: Completed
Publish Date: August 21, 2020
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

5 Total Publications

Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer.
Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 01, 2023
Similar Doctors
Expertise in
20
conditions
Dr. Stephen Miller
Hematology | Oncology
Expertise in
20
conditions
Dr. Stephen Miller
Hematology | Oncology

Starr Regional Medical Center

1114 W Madison Ave, 
Athens, TN 
 (42.5 miles away)
423-744-3153
Languages Spoken:
English
See accepted insurances

Stephen Miller is a Hematologist and an Oncologist in Athens, Tennessee. Dr. Miller is highly rated in 20 conditions, according to our data. His top areas of expertise are Inflammatory Breast Cancer, Non-Hodgkin Lymphoma, Paget Disease of the Breast, and Anemia.

Expertise in
12
conditions
Dr. Mark Hendrixson
Hematology | Oncology
Expertise in
12
conditions
Dr. Mark Hendrixson
Hematology | Oncology

Mark Neal Hendrixson MD

707 S Main St, 
Crossville, TN 
 (51.3 miles away)
931-456-8435
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mark Hendrixson is a Hematologist and an Oncologist in Crossville, Tennessee. Dr. Hendrixson is highly rated in 12 conditions, according to our data. His top areas of expertise are Breast Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Familial Colorectal Cancer.

Expertise in
66
conditions
Dr. Richard Lee
Hematology
Expertise in
66
conditions
Dr. Richard Lee
Hematology

Tennessee Cancer Specialists PLLC

1415 Old Weisgarber Rd Ste 200, 
Knoxville, TN 
 (5.7 miles away)
865-934-5800
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Richard Lee is a Hematologist in Knoxville, Tennessee. Dr. Lee is highly rated in 66 conditions, according to our data. His top areas of expertise are Childhood Iron Deficiency Anemia, Paget Disease of the Breast, Lung Cancer, and Angiosarcoma.

Frequently Asked Questions about Dr. Russell Devore

How do I make an appointment with Dr. Russell Devore?

You can book an appointment with Dr. Russell Devore by calling their office at 865-934-5800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Russell Devore a top-rated expert for Hypersplenism?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Russell Devore is classified as an Distinguished expert for Hypersplenism, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Russell Devore specialize in?

While Dr. Russell Devore is a Hematology, they have specific expertise in Hypersplenism, Pleuropulmonary Blastoma, and Childhood Iron Deficiency Anemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Russell Devore participate in research or clinical trials?

Yes. Dr. Russell Devore has published 5 articles and abstracts on conditions like Hypersplenism. You can view a list of Dr. Russell Devore's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Devore's expertise for a condition
ConditionClose
    View All 45 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile